secwatch.observer — SEC 8-K summary
======================================

Issuer:     EKSO BIONICS HOLDINGS, INC. (CHRN)
CIK:        0001549084
Form:       8-K
Filed at:   2022-01-21T23:59:59+00:00
Accession:  0001104659-22-006468
Event type: leadership
Sentiment:  neutral
Materiality: 0.70
Item codes: 5.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Ekso Bionics CEO Peurach resigns; Chairman Sherman becomes CEO
--------------------------------------------------------------

- CEO Jack Peurach resigns effective Jan 21, 2022; receives severance of 9 months salary, $187,250 lump sum, and RSU acceleration.
- Chairman Steven Sherman appointed CEO effective Jan 22; will receive equity award in lieu of $453K annual cash salary.
- Scott Davis promoted to President and COO from EVP Strategy and Corporate Development.
- Board appoints new committee chairs; Stanley Stern becomes Lead Independent Director.
- Press release notes record Q4 2021 revenue and momentum in inpatient rehab and industrial sales.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1549084/000110465922006468/0001104659-22-006468-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1549084/000110465922006468/tm223985d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-22-006468

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer